Precision medicine is an emerging framework to maximize therapeutic benefit by modifying the treatment for individual patients based on their variations in demographic, genomic, and environmental factors. In particular, "Pharmacogenomics" and "Therapeutic Drug Monitoring" are key elements of individualized ...
Public values and guiding principles for implementing epitope compatibility in kidney transplantation allocation criteria: results from a Canadian online p... Epitope compatibility in deceased donor kidney allocation is an emerging area of precision medicine (PM), seeking to improve compatibility between do...
The introduction of precision medicine may offer significant prospects to improve access as a form of preventative and diagnostic care and therefore equity with respect to health care services for racialized communities in Canada. Barriers for racialized communities to access these health innovations, howe...
Precision medicine expands treatment options and approaches for patients, including traditional cancer therapies and emerging targeted therapies, with the aim of achieving the best possible outcome for the patient5 Footnotes: CNS, central nervous system; NGS, next-generation sequencing; NSCLC, non-small...
With our findings, we believe that our proposed hypertension treatment recommendation model could assist doctors in prescribing appropriate antihypertensive medications. Keywords: precision medicine; hypertension; diabetes; reinforcement learning; Q-learning; treatment recommendation; healthcare management...
IPMC 2025 is an International Precision Medicine and Personalized Medicine conference which gathers experts from all over the globe during March 13-15 at Rome, Italy
Methods: We reviewed the impact, prevalence, economic burden, causes of kidney disease, and priority research areas in Canada. After reviewing the priority areas for kidney research, potential avenues for future research that can integrate precision medicine initiatives for pati...
(Canada), LifeOmic Health, LLC (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US), IBM Watson Group (US), and Koninklijke Philips N.V. (Netherlands) are the key players in the precision medicine software market. Syapse is one of the leading players ...
A total of ＄9 billion was allocated, compared with ＄215 million announced for the Precision Medicine Initiative in the United States.[2] In the area of genomic data collection and analysis, the Beijing Genome Institute is one of the world's largest sequencers and repositories of genetic ...
10.03.2024 Seattle, WA and Miamisburg, OH – October 3, 2024 – RevealDx and Riverain Technologies, leaders in the detection and characterization of lung nodules, announced the integration of their products, as well as distribution by Riverain in Canada. Both companies will be exhibiting at th...